Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Martinez

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
JACC. Case Reports|July 2, 2024
Mavacamten in Right Ventricular Outflow Tract ObstructionJasmine K Malhi, Richard T Carrick, Chloe Duvall, et al.
Journal of the American College of Cardiology|March 18, 2015
COCATS 4 Task Force 8: Training in Cardiovascular Magnetic Resonance ImagingChristopher M Kramer, W Gregory Hundley, Raymond Y Kwong, et al.
Expert Opinion on Pharmacotherapy|June 5, 2023
Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathyAkiva Rosenzveig, Neil Garg, Shiavax J Rao, et al.
Recent Patents on Cardiovascular Drug Discovery|January 19, 2012
Venous thromboembolism in patients with heart failure: in-hospital and chronic use of anti-coagulants for preventionNasir Shariff, Abdul Aleem, Vadim Levin, et al.
The American Journal of Cardiology|November 7, 2024
Efficacy of Cardiac Myosin Inhibition in Patients After Septal Reduction TherapyAakash Bavishi, Robyn Bryde, Marybeth Soutar, et al.
Archives of Cardiovascular Diseases|December 2, 2017
Regional and seasonal variations in heart failure admissions and mortality in the USAMahek Shah, Soumya Patnaik, Brijesh Patel, et al.
Recent Patents on Cardiovascular Drug Discovery|August 13, 2011
Atrial fibrillation following cardiac surgery: established and emerging strategies of preventionNasir Shariff, Abdul Aleem, Larry E Jacobs, et al.
JACC. Advances|December 30, 2024
Mavacamten: Initial Insights From the Risk Evaluation and Mitigation Strategy ProgramMatthew W Martinez, Dewey Seto, Michael Cheung, et al.
International Journal of Cardiology|October 8, 2017
The day of the week and acute heart failure admissions: Relationship with acute myocardial infarction, 30-day readmission rate and in-hospital mortalityMahek Shah, Soumya Patnaik, Brijesh Patel, et al.
Circulation. Heart Failure|November 11, 2024
Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) ProgramMilind Y Desai, Dewey Seto, Michael Cheung, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
JACC. Case Reports|July 2, 2024
Mavacamten in Right Ventricular Outflow Tract ObstructionJasmine K Malhi, Richard T Carrick, Chloe Duvall, et al.
Journal of the American College of Cardiology|March 18, 2015
COCATS 4 Task Force 8: Training in Cardiovascular Magnetic Resonance ImagingChristopher M Kramer, W Gregory Hundley, Raymond Y Kwong, et al.
Expert Opinion on Pharmacotherapy|June 5, 2023
Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathyAkiva Rosenzveig, Neil Garg, Shiavax J Rao, et al.
Recent Patents on Cardiovascular Drug Discovery|January 19, 2012
Venous thromboembolism in patients with heart failure: in-hospital and chronic use of anti-coagulants for preventionNasir Shariff, Abdul Aleem, Vadim Levin, et al.
The American Journal of Cardiology|November 7, 2024
Efficacy of Cardiac Myosin Inhibition in Patients After Septal Reduction TherapyAakash Bavishi, Robyn Bryde, Marybeth Soutar, et al.
Archives of Cardiovascular Diseases|December 2, 2017
Regional and seasonal variations in heart failure admissions and mortality in the USAMahek Shah, Soumya Patnaik, Brijesh Patel, et al.
Recent Patents on Cardiovascular Drug Discovery|August 13, 2011
Atrial fibrillation following cardiac surgery: established and emerging strategies of preventionNasir Shariff, Abdul Aleem, Larry E Jacobs, et al.
JACC. Advances|December 30, 2024
Mavacamten: Initial Insights From the Risk Evaluation and Mitigation Strategy ProgramMatthew W Martinez, Dewey Seto, Michael Cheung, et al.
International Journal of Cardiology|October 8, 2017
The day of the week and acute heart failure admissions: Relationship with acute myocardial infarction, 30-day readmission rate and in-hospital mortalityMahek Shah, Soumya Patnaik, Brijesh Patel, et al.
Circulation. Heart Failure|November 11, 2024
Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) ProgramMilind Y Desai, Dewey Seto, Michael Cheung, et al.
Pageof 15